Format

Send to

Choose Destination
See comment in PubMed Commons below
Crit Care Med. 2009 Jun;37(6):1893-7. doi: 10.1097/CCM.0b013e31819fffd3.

Metabolic benefits of surface counter warming during therapeutic temperature modulation.

Author information

1
Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA. nbadjatia@neuro.columbia.edu

Abstract

OBJECTIVE:

To determine the impact of counter warming (CW) with an air circulating blanket on shivering and metabolic profile during therapeutic temperature modulation (TTM).

DESIGN:

A prospective observational study.

SETTING:

An 18-bed neurologic intensive care unit.

PATIENTS:

Fifty mechanically ventilated patients with brain injury undergoing TTM with automated surface and intravascular devices.

INTERVENTIONS:

Fifty indirect calorimetry (IDC) measurements with and without CW during TTM.

MEASUREMENTS AND MAIN RESULTS:

IDC was continuously performed for 10-15 minutes at baseline with CW (phase I), off CW (phase II), and again after the return of CW (phase III). Shivering severity during each phase was scored on a scale of 0-3 using the Bedside Shivering Assessment Scale (BSAS). Resting energy expenditure (REE), oxygen consumption, and carbon dioxide production were determined by IDC; 56% were women, with mean age 61 +/- 15 years. At the time of IDC, 72% of patients had signs of shivering (BSAS >0). All measures of basal metabolism increased after removal of the air warming blanket (from phases I and II); REE increased by 27% and oxygen consumption by 29% (both p < 0.002). A one-point increase in baseline BSAS was noted in 55% (n = 23/42) of patients from phase I to phase II. In a multivariate analysis, sedative use (p = 0.03), baseline moderate to severe shivering (p = 0.04), and lower serum magnesium levels (p = 0.01) were associated with greater increases in REE between phase I and phase II of CW. Phase III of CW was associated with a reversal in the increases in all metabolic variables.

CONCLUSIONS:

Surface CW provides beneficial control of shivering and improves the metabolic profile during TTM.

PMID:
19384208
DOI:
10.1097/CCM.0b013e31819fffd3
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center